J B Chemicals &

{
  "main_header": {
    "sid": 461857,
    "name": "J B Chemicals &",
    "stock_name": "J B Chemicals &",
    "full_name": "J B Chemicals & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/j-b-chemicals-",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,094.30",
    "chg": -41,
    "chgp": "-1.92%",
    "dir": -1,
    "prev_price": "2,135.30",
    "mcapval": "33,964.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506943,
    "symbol": "JBCHEPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE572A01036",
    "curr_date": "May 13",
    "curr_time": "",
    "bse_nse_vol": "3.9 lacs",
    "exc_status": "Active",
    "traded_date": "May 13, 2026",
    "traded_date_str": "2026 05 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/j-b-chemicals--461857-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Are J B Chemicals & Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-j-b-chemicals-pharmaceuticals-ltd-latest-results-good-or-bad-3988018",
        "imagepath": "",
        "date": "2026-05-12 19:15:29",
        "description": "J B Chemicals & Pharmaceuticals Ltd's latest financial results for Q4 FY26 reveal significant challenges, particularly in terms of profitability and sales performance. The company reported a net profit of ₹101.37 crore, which reflects a notable sequential decline of 48.77% from the previous quarter and a year-on-year decrease of 30.42%. This sharp drop in profit raises concerns about the sustainability of the company's earnings.\n\nNet sales for the same quarter amounted to ₹904.23 crore, marking a sequential decline of 15.07% from ₹1,064.72 crore in Q3 FY26 and a year-on-year decrease of 4.77%. This decline in revenue indicates potential cyclical and structural challenges within the business, as it represents the lowest quarterly revenue in FY26.\n\nThe operating profit margin, excluding other income, contracted to 22.24%, down from 27.78% in the previous quarter, indicating significant margin compression. Thi..."
      },
      {
        "title": "J B Chemicals Q4 FY26: Sharp Profit Decline Amid Margin Pressure Raises Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/j-b-chemicals-q4-fy26-sharp-profit-decline-amid-margin-pressure-raises-concerns-3987989",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JBChemicalsPhar_quaterlyResult_3987989.png",
        "date": "2026-05-12 16:46:45",
        "description": "J B Chemicals & Pharmaceuticals Ltd. reported a concerning Q4 FY26 performance, with net profit plunging 48.77% quarter-on-quarter to ₹101.37 crores and declining 30.42% year-on-year. The sharp contraction in profitability, coupled with sequential revenue decline of 15.07% to ₹904.23 crores, has raised red flags about the company's operational momentum. Following the results announcement, shares traded at ₹2,133.80 on May 12, 2026, down 3.35% from the previous close, reflecting investor disappointment with the pharmaceutical manufacturer's performance."
      },
      {
        "title": "J B Chemicals & Pharmaceuticals Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/j-b-chemicals-pharmaceuticals-ltd-technical-momentum-shifts-to-bullish-amid-strong-price-gains-3986416",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JBChemicalsPhar_technicaldot_3986416.png",
        "date": "2026-05-12 08:03:13",
        "description": "J B Chemicals & Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators. The stock’s recent performance, coupled with upgrades in its technical trend and a revised Mojo Grade, signals renewed investor interest amid a challenging market backdrop."
      },
      {
        "title": "Broad-Based Technical Strength Lifts J B Chemicals & Pharmaceuticals Ltd to 52-Week High of Rs 2197",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/j-b-chemicals-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2197-3985593",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JBChemicalsPhar_priceRelatedfactors_3985593.png",
        "date": "2026-05-11 11:10:08",
        "description": "Surging to a fresh 52-week high of Rs 2197 on 11 May 2026, J B Chemicals & Pharmaceuticals Ltd has demonstrated robust price momentum, outperforming its sector and the broader market despite a declining Sensex. The stock’s six-day consecutive gain, delivering a 7.27% return in that span, underscores a sustained technical uptrend that has propelled it well above key moving averages."
      },
      {
        "title": "When is the next results date for J B Chemicals & Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-j-b-chemicals-pharmaceuticals-ltd-3978468",
        "imagepath": "",
        "date": "2026-05-06 23:16:09",
        "description": "The next results date for J B Chemicals & Pharmaceuticals Ltd is scheduled for 11 May 2026...."
      },
      {
        "title": "J B Chemicals & Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/j-b-chemicals-pharmaceuticals-ltd-is-rated-hold-3972983",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JBChemicalsPhar_mojoScore_3972983.png",
        "date": "2026-05-03 10:10:02",
        "description": "J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "J B Chemicals & Pharmaceuticals Ltd: Technical Momentum Shifts Signal Cautious Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/j-b-chemicals-pharmaceuticals-ltd-technical-momentum-shifts-signal-cautious-outlook-3969412",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JBChemicalsPhar_technicaldot_3969412.png",
        "date": "2026-04-30 08:01:10",
        "description": "J B Chemicals & Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late April 2026. While the stock price has shown resilience with a 0.95% gain on the day, a detailed analysis of key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands reveals a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "J B Chemicals & Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/j-b-chemicals-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-3965515",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JBChemicalsPhar_technicaldot_3965515.png",
        "date": "2026-04-28 08:02:17",
        "description": "J B Chemicals & Pharmaceuticals Ltd has experienced a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend. Despite mixed signals from key indicators such as MACD and RSI, the stock’s recent performance and moving averages suggest growing investor confidence in this pharmaceuticals & biotechnology small-cap."
      },
      {
        "title": "J B Chemicals & Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/j-b-chemicals-pharmaceuticals-ltd-is-rated-hold-3956693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JBChemicalsPhar_mojoScore_3956693.png",
        "date": "2026-04-22 10:10:21",
        "description": "J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 414,
    "sid": "461857",
    "stock_news_url": "https://www.marketsmojo.com/news/j-b-chemicals-pharmaceuticals-461857"
  },
  "announcements": [
    {
      "details": "JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Approval for re-classification of certain promoter group members to public'.",
      "source": "NSE",
      "caption": "JB Chemicals & Pharmaceuticals Limited - Updates",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "JB Chemicals & Pharmaceuticals Limited - Other General Purpose",
      "datetime": "21-Nov-2019"
    },
    {
      "details": "JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of Public Announcement - Buyback of Shares.",
      "source": "NSE",
      "caption": "JB Chemicals & Pharmaceuticals Limited - Public Announcement-Buyback of Shares",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "J B Chemicals & Pharmaceuticals Ltd has declared <strong>1270%</strong> dividend, ex-date: 11 Feb 26",
          "dt": "2026-02-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "J B Chemicals & Pharmaceuticals Ltd has announced <strong>1:2</strong> stock split, ex-date: 18 Sep 23",
          "dt": "2023-09-18",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are J B Chemicals & Pharmaceuticals Ltd latest results good or bad?

2026-05-12 19:15:29

J B Chemicals & Pharmaceuticals Ltd's latest financial results for Q4 FY26 reveal significant challenges, particularly in terms of profitability and sales performance. The company reported a net profit of ₹101.37 crore, which reflects a notable sequential decline of 48.77% from the previous quarter and a year-on-year decrease of 30.42%. This sharp drop in profit raises concerns about the sustainability of the company's earnings. Net sales for the same quarter amounted to ₹904.23 crore, marking a sequential decline of 15.07% from ₹1,064.72 crore in Q3 FY26 and a year-on-year decrease of 4.77%. This decline in revenue indicates potential cyclical and structural challenges within the business, as it represents the lowest quarterly revenue in FY26. The operating profit margin, excluding other income, contracted to 22.24%, down from 27.78% in the previous quarter, indicating significant margin compression. Thi...

Read full news article

J B Chemicals Q4 FY26: Sharp Profit Decline Amid Margin Pressure Raises Concerns

2026-05-12 16:46:45

J B Chemicals & Pharmaceuticals Ltd. reported a concerning Q4 FY26 performance, with net profit plunging 48.77% quarter-on-quarter to ₹101.37 crores and declining 30.42% year-on-year. The sharp contraction in profitability, coupled with sequential revenue decline of 15.07% to ₹904.23 crores, has raised red flags about the company's operational momentum. Following the results announcement, shares traded at ₹2,133.80 on May 12, 2026, down 3.35% from the previous close, reflecting investor disappointment with the pharmaceutical manufacturer's performance.

Read full news article

J B Chemicals & Pharmaceuticals Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains

2026-05-12 08:03:13

J B Chemicals & Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators. The stock’s recent performance, coupled with upgrades in its technical trend and a revised Mojo Grade, signals renewed investor interest amid a challenging market backdrop.

Read full news article

Broad-Based Technical Strength Lifts J B Chemicals & Pharmaceuticals Ltd to 52-Week High of Rs 2197

2026-05-11 11:10:08

Surging to a fresh 52-week high of Rs 2197 on 11 May 2026, J B Chemicals & Pharmaceuticals Ltd has demonstrated robust price momentum, outperforming its sector and the broader market despite a declining Sensex. The stock’s six-day consecutive gain, delivering a 7.27% return in that span, underscores a sustained technical uptrend that has propelled it well above key moving averages.

Read full news article

When is the next results date for J B Chemicals & Pharmaceuticals Ltd?

2026-05-06 23:16:09

The next results date for J B Chemicals & Pharmaceuticals Ltd is scheduled for 11 May 2026....

Read full news article

J B Chemicals & Pharmaceuticals Ltd is Rated Hold

2026-05-03 10:10:02

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

J B Chemicals & Pharmaceuticals Ltd: Technical Momentum Shifts Signal Cautious Outlook

2026-04-30 08:01:10

J B Chemicals & Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late April 2026. While the stock price has shown resilience with a 0.95% gain on the day, a detailed analysis of key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands reveals a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

J B Chemicals & Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-04-28 08:02:17

J B Chemicals & Pharmaceuticals Ltd has experienced a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend. Despite mixed signals from key indicators such as MACD and RSI, the stock’s recent performance and moving averages suggest growing investor confidence in this pharmaceuticals & biotechnology small-cap.

Read full news article

J B Chemicals & Pharmaceuticals Ltd is Rated Hold

2026-04-22 10:10:21

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News